 | Immuno-Oncology Call for Papers Journal Information Journal Title (English): Immuno-Oncology Journal Title (Chinese): 《免疫肿瘤学》 ISSN: 3105-6628 (print) / 3105-6636 (online) Publishing Model: Gold Open Access (under CC BY 4.0 license) Publisher: Macau Sino-Foreign Medical Publishing Limited Publication Frequency: Bimonthly Language of Submission: Chinese (must include English title, abstract, keywords, and author affiliations/names) Core Focus Immuno-Oncology is a pioneering academic journal focusing on basic research and clinical translation in tumor immunology. The journal is dedicated to advancing innovative breakthroughs in the field of cancer immunotherapy, with particular emphasis on exploring key scientific issues including immune checkpoint mechanisms, tumor microenvironment regulation, cell therapy technologies, and biomarker development. We particularly encourage multidisciplinary research approaches that integrate cutting-edge technologies from immunology, oncology, molecular biology, and bioinformatics to provide solid theoretical foundations and innovative strategies for clinical practice in cancer immunotherapy. Scope We welcome submissions in the following areas: Mechanisms of Immune Checkpoint Inhibitors and Resistance Studies Innovation and Application of Cell Therapy Technologies (CAR-T/NK/TCR-T, etc.) Dynamic Regulation Mechanisms of Tumor Immune Microenvironment Tumor Neoantigens and Personalized Immunotherapy Discovery and Validation of Immunotherapy Biomarkers Mechanisms and Management of Immune-Related Adverse Events Cancer Vaccines and Combination Therapy Strategies Microbiome and Tumor Immune Responses Synergistic Effects of Radiotherapy and Immunotherapy Clinical Trials and Real-World Evidence in Immunotherapy Global Call for Editorial Board Members/Associate Editors/Peer Reviewers/Editor-in-Chief We cordially invite experts and scholars in the field of immuno-oncology worldwide to join our academic team and collectively advance disciplinary development. Apply online at: http://tg.scionline2025.com/01/bw.asp Online Submission Please submit your manuscripts via: http://tg.scionline2025.com/01/ Aims and Vision Our goal is to establish Immuno-Oncology as an internationally authoritative academic platform in the field, promoting the rapid translation of basic research into clinical therapy. We are committed to building a global academic collaboration network, providing researchers, clinicians, and industry experts with a high-level exchange platform, driving innovation in cancer immunotherapy, and benefiting patients worldwide. Global Indexing Plan The journal registers unique DOI identifiers for all published articles and is pursuing inclusion in the following major academic databases: Science Citation Index Expanded (SCIE) MEDLINE/PubMed Scopus Embase DOAJ (Directory of Open Access Journals) Google Scholar Baidu Scholar Wanfang Data VIP Information Macau Virtual Library Longyuan Journal Network Chaoxing Academic Platform Yangtze River Database Xinhuanet Academic China CNKI (China National Knowledge Infrastructure) | ||
| Published by | Macau Sino-Foreign Medical Publishing Limited | ||
| Year publication | 2025 | Frequency (Publish per Year) | 6 |
| ISSN (print) | 3105-6628 | ISSN (online) | 3105-6636 |
| Journal discipline | Medical Sciences | Full text language | Chinese, English |
| Journal Website | http://myzlx.scionline2025.com | ||
| Editor in Chief | guō yǔ chén | ||
| Abbreviated Name | CODEN：MZABB7 | Country | Macau |
| ISI | Scopus | ||
| Journal is indexed by | DOI，Crossref，Index Copernicus.Poland，EuroPub Publishing Company.Britain，Academia.edu.America，ResearchBib.Japan，Vanderbilt University Medical Center.America，LivRe（livre.cnen.gov.br）.Brazil，Research Center for Chinese Science Evaluation.RCCSE，YangtzeRiverRepos.China，Eurasian Science Journal Index(ESJI).Kazakhstan，Sci Online，Baidu Baike.China，CNKI.China，Wanfang Data.China，VIP.China，Zhongyou Reading.China，Longyuan Journals Network.China，uperStar Database.China，Macao Virtual Library.China，ASCI，GoogleScholar，Baidu Scholar.China，Open Access Library(OALib).America，Kind Congress, KindCongress | ||
| Impact Factor | Date added to KC | 04 Jan 2026 | |
October 14, 2026
October 14, 2026
